Is the U.S. Losing Its Biotech Edge to China? Senate Hearing & Innovation Outlook
In this episode of Making Medicine, host John Stanford unpacks the Senate HELP Committee hearing on “The Future of Biotech.” From China’s accelerating investment to U.S. policy uncertainty, he explores what’s needed to protect American leadership in life sciences. The episode also covers new White House biosimilar announcements, gene therapy market challenges, and early insights from Incubate Policy Lab’s investment analysis. With over $14 billion invested in early-stage biotech this year, the conversation turns to what’s next for U.S. innovation.
Do you think U.S. biotech can stay ahead of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.